Kurzfassung

An open, randomized phase III clinical study to compare standard versus predefined use of Plerixafor for mobilization of autologous peripheral blood stem cells and to compare autologous with allogeneic stem cell transplantation as treatment of primary progressive and relapsed aggressive B-cell Non-Hodgkin Lymphoma via risk adapted stratification. Allogeneic Stem Cell Transplantation in Relapsed Aggressive Non-Hodgkin Lymphoma (ASTRAL)